Dr. Jha is a Senior Research Fellow in the Department of Diabetes at the School of Translational Medicine, where he leads innovative research focused on discovering novel therapeutic targets and biomarkers for diabetes, kidney disease, and cardiorenal syndrome.

He earned his PhD from Monash University in 2014, with his thesis providing the scientific rationale for clinical trials investigating NOX inhibitors in diabetic kidney disease. In 2015, he began his postdoctoral research at the Baker Heart and Diabetes Institute. His contributions were soon recognised with the prestigious Juvenile Diabetes Research Foundation (JDRF) International Postdoctoral Fellowship in 2016, enabling him to further advance his work in diabetes and renal disease.

In 2017, Dr. Jha was awarded the highly competitive NHMRC Peter Doherty Early Career Research Fellowship, which coincided with his transition to the newly established Monash Diabetes Department. Demonstrating his commitment to international research collaboration, he spent time as a visiting scholar at the German Diabetes Centre in Düsseldorf in 2022.

Dr. Jha is actively engaged in the scientific community through memberships in several professional societies, including the Australian Diabetes Society (ADS), the Australian and New Zealand Society of Nephrology (ANZSN), the American Society of Nephrology (ASN), and the European Association for the Study of Diabetes (EASD).

His research has been published in leading journals in the fields of diabetes, nephrology, and oxidative stress, and is widely cited—with over 3,500 citations and an H-index of 24 as of July 2025—underscoring the impact and relevance of his work. He has consistently secured competitive funding, including multiple grants from Diabetes Australia (2020, 2022, 2023, and 2024), and in 2025, he was awarded the FMNHS Future Leader Postdoctoral Fellowship—a testament to his sustained excellence and leadership in the field.

With a strong track record of impactful research and a clear vision for improving health outcomes, Dr. Jha continues to lead advances in translational science in diabetes and kidney disease.

• Oxidative stress – inflammation – fibrosis axis in diabetes and related complications
• Human 3D kidney organoids
• Translation of novel therapeutic targets
• NOX pathways
• Predictive tools and biomarkers of diabetes and kidney disease